2012-09-17 05:52:57 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's pharmaceuticals report, "Wellstat Therapeutics Corporation - Product Pipeline Review - 2012" provides data on the Wellstat Therapeutics Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Wellstat Therapeutics Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Wellstat Therapeutics Corporation and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463556_wellstat_therapeutics_corporation_pro ..


Scope

* Wellstat Therapeutics Corporation - Brief Wellstat Therapeutics

Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Wellstat Therapeutics Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Wellstat Therapeutics Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Wellstat Therapeutics Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Wellstat Therapeutics Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Wellstat Therapeutics Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Wellstat Therapeutics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Wellstat Therapeutics Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Wellstat Therapeutics Corporation and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Wellstat Therapeutics Corporation; Wellstat Therapeutics Corporation - Key Therapeutics; Wellstat Therapeutics Corporation - Pipeline Overview and Promising Molecules; Wellstat Therapeutics Corporation - News; Wellstat Therapeutics Corporation - Latest Updates; Wellstat Therapeutics Corporation - Pipeline; Wellstat Therapeutics Corporation - Discontinued/Dormant Projects

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Wellstat Therapeutics Corporation Snapshot
Wellstat Therapeutics Corporation Overview
Key Information
Key Facts
Wellstat Therapeutics Corporation - Research and Development Overview
Key Therapeutic Areas
Wellstat Therapeutics Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Wellstat Therapeutics Corporation - Pipeline Products Glance
Wellstat Therapeutics Corporation - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Wellstat Therapeutics Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Wellstat Therapeutics Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Wellstat Therapeutics Corporation - Drug Profiles
Gemcitabine
Product Description
Mechanism of Action
R&D Progress
PN-401
Product Description
Mechanism of Action
R&D Progress
PN2XXX
Product Description
Mechanism of Action
R&D Progress
PN401 + 5-fluorouracil
Product Description
Mechanism of Action
R&D Progress
PN951
Product Description
Mechanism of Action
R&D Progress
PNXXXX
Product Description
Mechanism of Action
R&D Progress
Wellstat Therapeutics Corporation - Pipeline Analysis
Wellstat Therapeutics Corporation - Pipeline Products by Therapeutic Class
Wellstat Therapeutics Corporation - Pipeline Products by Route of Administration
Wellstat Therapeutics Corporation - Pipeline Products By Mechanism of Action
Wellstat Therapeutics Corporation - Recent Pipeline Updates
Wellstat Therapeutics Corporation - Locations And Subsidiaries
Head Office
Financial Deals Landscape
Wellstat Therapeutics Corporation, Deals Summary
Wellstat Therapeutics Corporation, Pharmaceuticals & Healthcare, Deal Details
Licensing Agreements
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate
BTG Enters Into Licensing Agreement With Wellstat Therapeutics For Uridine Triacetate

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463556&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.